Klent Pharmacs Private Limited - Company Profile

It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2008.
2008 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Klent Pharmacs Private Limited

Klent Pharmacs Private Limited, a active private limited company, was established on 31 March 2008 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230TN2008PTC067117. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M.

It upholds a active non-compliant status. Its leadership includes Vanitha Ramesh (Director), Ramesh Tenambhat Krishnamurthy (Director). Past directors included Pushpa Bohara. It holds ₹1.60 Cr open charges and no settled loans. It is based at 9, First Floor, Krishnabai Street T.Nagar, Chennai, Tamil Nadu, 600017.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230TN2008PTC067117

  • Registration Number

    067117

  • Incorporation Date

    31 March 2008

  • Authorized Capital

    ₹1.00 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Company Age 18 Year, 2 Months
  • Open Charges ₹ 1.60 Cr
Company report

Klent Pharmacs Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Klent Pharmacs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Klent Pharmacs Private Limited?
Current Directors
Name Designation Appointment Date Status
Vanitha Ramesh Director 31 Mar 2008 Current
Ramesh Tenambhat Krishnamurthy Director 31 Mar 2008 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 22 Jul 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Klent Pharmacs.

Enhance accessibility to Klent Pharmacs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Klent Pharmacs revenue growth over time
Klent Pharmacs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Klent Pharmacs?

Unlock access to Klent Pharmacs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹16,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Tamilnad Mercantile Bank Ltd : 1.60 Cr
Latest Charge Details
Date Lender Amount Status
01 Aug 2008 Tamilnad Mercantile Bank Ltd ₹1.60 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Klent Pharmacs?

Unlock and access historical data on people associated with Klent Pharmacs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Klent Pharmacs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Klent Pharmacs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Klent Pharmacs
Recent Activity within the Organization
  • Charges

    The activity A charge with Tamilnad Mercantile Bank Ltd amounted to Rs. 16.00 M with Charge ID 10119912 was registered on 01 Aug 2008. was completed.

  • Director Appointment

    Vanitha Ramesh was appointed as a Director was appointed as a Director on 31 Mar 2008 & has been associated with this company since 18 years 2 months . was recorded as a recent event.

  • Director Appointment

    The activity Ramesh Tenambhat Krishnamurthy was appointed as a Director was appointed as a Director on 31 Mar 2008 & has been associated with this company since 18 years 2 months . was completed.

  • Company Incorporation

    Klent Pharmacs Private Limited was registered on 31 Mar 2008 with Roc Chennai & aged 18 years 2 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Klent Pharmacs Private Limited?

The CIN of Klent Pharmacs Private Limited is U24230TN2008PTC067117.

Where is Klent Pharmacs Private Limited headquartered?

Klent Pharmacs Private Limited is headquartered at 9, First Floor, Krishnabai Street T.Nagar, Chennai, Tamil Nadu, 600017.

When was Klent Pharmacs Private Limited incorporated?

Klent Pharmacs Private Limited was incorporated on 31 March 2008.

Who are the current directors of Klent Pharmacs Private Limited?

The current directors of Klent Pharmacs Private Limited are

What is the primary industry of Klent Pharmacs Private Limited?

The primary industry of Klent Pharmacs Private Limited is Pharma.

Is Klent Pharmacs Private Limited a listed company?

Klent Pharmacs Private Limited is unlisted.

What is the compliance status of Klent Pharmacs Private Limited?

The compliance status of Klent Pharmacs Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available